Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction.
Nadav Liam Modlin, Zsofia Elek, Carolina Maggio, Manish Agrawal, Lauren Lepow, James Rucker, Joanne Stubley, Jeffrey Guss
Psychodynamic psychiatry June 1, 2026 Peer reviewed DOI: 10.1521/pdps.2026.54.2.338 via PubMed
Summary
Psychedelic therapy has shown promise for treating conditions like depression and PTSD, but the role of unconscious material during these experiences is less understood. This article proposes a psychodynamically informed approach to help clinicians work with unconscious content that may emerge in psychedelic states. By integrating psychoanalytic theory with clinical practice, it emphasizes the importance of considering unconscious communication and symbolic processes to enhance therapeutic outcomes beyond mere symptom relief.
Study at a glance
| Key finding | The article argues that psychoanalytic models can provide valuable insights into the mechanisms of change in psychedelic therapy beyond just reducing symptoms. |
|---|
Abstract
Recent clinical trials have suggested the safety and efficacy of psychedelic therapy for treatment-resistant depression, posttraumatic stress disorder, addiction, and end-of-life distress. While neurobiological mechanisms such as 5-HT2A receptor activation, increased neural entropy, and default mode network modulation have been well-characterized, significantly less attention has been given to the emergence of unconscious material within psychedelic states. This article introduces a psychodynamically informed framework for understanding and working with such material in clinical contexts. Drawing on psychoanalytic theory, we explore how psychedelic compounds may facilitate access to preverbal, dissociated, and developmentally embedded psychic content, often expressed through somatic experience, symbolic imagery, and unconstrained affect. Using the four standard phases of psychedelic screening, preparation, psychedelic treatment session, and follow-up or integration, we present a structured psychodynamic lens, integrating conceptual theory with illustrative clinical vignettes. These fictional composites, informed by publicly funded clinical research programs, highlight how unspoken experience, affective intensity, and shifts in psychic structure may unfold within the psychedelic experience. We argue that consideration of unconscious communication, symbolic processes, and defensive functioning can foster greater clinical depth. This article advances the position that psychoanalytic models, though underrepresented in current psychedelic research, offer valuable tools for conceptualizing mechanisms of change beyond symptom reduction. As psychedelic treatments approach regulatory approval and broader clinical use, such perspectives may play an important role in future research, training, supervision, and individualized care models.